In phase 1 and 2 studies (NCT04524351), respectively, people with early Alzheimer disease (AD) and early Parkinson disease (PD) who were treated with posiphen (ANVS401; Annovis, Berwyn, PA) had statistically significant clinical improvements. Changes in biomarkers of neurodegeneration and neuroinflammation were also observed. Posiphen is an orally administered translational inhibitor of neurotoxic proteins that form […]

Biotricity (BTCY) is a medical technology company that develops solutions to aid in chronic diseases prevention and management. Dr. Waqaas Al-Siddiq, Chairman, CEO, and Founder of Biotricity, gives an overview of the company and discusses the stock. He also talks about Bioflux which is a mobile cardiac telemetry device and BTCY’s lead product. Tune into […]

DarioHealth (DRIO) stock price was up almost 4% in the last 5 days. The company offers digital therapeutic solutions to customers. This covers multiple chronic conditions including diabetes, hypertension, and behavioral health. CEO Dr. Erez Raphael weighs in on telehealth versus digital therapeutics. Also, he covers the growth strategy for 2022.